Wyeth obtains U.S. approval for Premarin's expanded use
The FDA is allowing Wyeth to market its Premarin cream to treat dyspareunia, or painful sexual intercourse, in postmenopausal women. The approval covers twice-weekly doses of the hormone-replacement drug, which is already sold as a treatment for hot flashes, vaginal dryness and other symptoms of menopause.
Forbes | 11/13
This story published in FMI Pharmacy dailyLead on 11/14/2008
More from SmartBrief:
Aurobindo's generic Aceon gains FDA approval
Thursday, November 12, 2009
FDA approves Salix's gastrointestinal drug Metozolv ODT
Wednesday, September 9, 2009
Get stories like these delivered daily for FREE:
|
FMI Pharmacy dailyLead
Designed specifically for pharmacy professionals, FMI Pharmacy dailyLead is a FREE, daily e-mail newsletter. It provides the latest news in the pharmacy arena. Learn more |
|